出处
《中国中西医结合肾病杂志》
2010年第6期552-554,共3页
Chinese Journal of Integrated Traditional and Western Nephrology
基金
国家自然科学基金资助项目(No.30600290)
上海市科委基金资助项目(No.044119620
07QA14040
08dz1900501)
参考文献42
-
1Mujais S,Nolph K,Gokal R.Evaluation and management of ultrafiltration problems in peritoneal dialysis.International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int,2000,20(Suppl 4):S5-S21.
-
2Reyes MJ,Bajo MA,Hevía C,et al.Inherent high peritoneal transport and ultrafiltration deficiency:their mid-term clinical relevance.Nephrol Dial Transplant,2007,22(1):218-223.
-
3Chung SH,Heimbürger O,Lindholm B.Poor outcomes for fast transporters on PD:the rise and fall of a clinical concern.Semin Dial,2008,21(1):7-10.
-
4ter Wee PM,van Ittersum FJ.The new peritoneal dialysis solutions:friends only,or foes in part?Nat Clin Pract Nephrol,2007,3(11):604-612.
-
5Rumpsfeld M,McDonald SP,Johnson DW.Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian a nd New Zealand peritoneal dialysis patient populations.J Am Soc Nephrol,2006,17(1):271-278.
-
6Brimble KS,Walker M,Margetts PJ,et al.Meta-analysis:peritoneal membrane transport,mortality,a nd technique failure in peritoneal dialysis.J Am Soc Nephrol,2006,17(9):2591-2598.
-
7Yang X,Fang W,Bargman JM,et al.High pertioneal permeability is not associated with higher mortality or technique failure in patients on zutomated peritoneal dialysis.Perit Dial Int,2008,28(1):82-92.
-
8Numata M,Nakayama M,Nimura S,et al.Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.Perit Dial Int,2003,23(2):116-122.
-
9Margetts PJ,Gyorffy S,Kolb M,et al.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol,2002,13(3):721-728.
-
10Pawlaczyk K,Kuzlan-Pawlaczyk M,Anderstam B,et al.Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis.Nephrol Dial Transplant,2001,16(3):669-671.
二级参考文献15
-
1Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation[J]. Mol Cell, 2000, 6(6) : 1365 -1375.
-
2Seharstohl A, Diepens R, Lensen J, a al. Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGF-β-mediated chondrocyte proliferation and proteoglyean synthesis [ J ]. Osteoarthritis Cartilage, 2003, 11 ( 11 ) : 773 - 782.
-
3Takase M, Imamura T, Sampath TK, et al. Induction of Smad6 mRNA by bone morphogenetic proteins[J]. Biochem Biophys Res Commun, 1998, 244(1): 26-29.
-
4Zhao J, Shi W, Chen H, et al. Smad7 and Smad6 differentially modulate transforming growth factor β-induced inhibition of embryonic lung morphogenesis [ J ]. J Biol Chem, 2000, 275 (31): 23992- 23997.
-
5Hilt-Kapturezak N, Truong L, Thamilselvan V, et al. Smad7-dependent regulation of heine oxygenase-1 by transforming growth factor-beta in human renal epithelial cells[ J]. J Biol Chem, 2000, 275 ( 52 ) : 40904 - 40909.
-
6Badid C, Vincent M, Fouque D, et al. Myofibroblast: a prognostic marker and target cell in progressive renal disease [ J ]. Ren Fail, 2001, 23(3 -4) : 543 -549.
-
7Bums WC, Kantharidis P, Thomas MC. The role of tubular epithelialmesenchymal transition in progressive kidney disease[ J]. Cells Tissues Organs, 2007, 185(1 -3) : 222 -231.
-
8Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis [ J ]. J Clin Invest, 2002, 110 (3) : 341 -350.
-
9Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility [ J ]. Nat Rev Mol Cell Biol, 2007, 8(12) : 970 -982.
-
10Mucsi I, Rosivall L. Epithelial-rnesenchymal transition in renal tubular ceils in the pathogenesis of progressive tubulo-interstitial fibrosis [J]. Acta Physiol Hung, 2007, 94(1 -2): 117 -131.
共引文献8
-
1姚岚,孟庆一,马欣,李东书,肖瑞崇.抗纤合剂对肺纤维化大鼠TGF-β/Smad信号通路调控的研究[J].辽宁中医药大学学报,2019,0(11):26-29. 被引量:3
-
2邹莎琳,凌光辉,夏运成,袁曙光,彭佑铭,孙林,刘伏友.EMT在腹膜纤维化中的作用及意义[J].中国中西医结合肾病杂志,2009,10(7):645-648. 被引量:10
-
3郝艳鹏,张悦.逆转肾小管上皮细胞转分化的Smad信号转导机制[J].生命科学,2010,22(2):169-172. 被引量:1
-
4陈刚毅,苏保林,孟立锋,汤水福.化痰祛瘀法对腹膜纤维化大鼠腹膜致密层厚度及SMA、E-cadherin蛋白表达的影响[J].湖南中医杂志,2011,27(5):126-127. 被引量:7
-
5陈刚毅,苏保林,孟立锋,汤水福.化痰祛瘀法对腹膜纤维化大鼠TGF-β/Smad信号通路的影响[J].广州中医药大学学报,2012,29(1):34-36. 被引量:6
-
6徐建伟,刘丽秋,吕海琳.高糖对小鼠足细胞表达Smad7的影响[J].医学信息,2013(4):267-268.
-
7李正红,盛梅笑,张旭,张露,朱长乐,杨劲松.黄芪对高糖腹透液诱导大鼠腹膜间皮细胞EMT中TGF-β1/Smads信号通路的影响[J].南京中医药大学学报,2013,29(3):227-232. 被引量:13
-
8孟立锋,杨端云,李吉武,覃志周,农邵阳.加味六君子汤对腹膜纤维化大鼠腹膜间皮细胞转分化的影响[J].中国中西医结合肾病杂志,2016,17(4):299-302. 被引量:14
同被引文献13
-
1张琪琦,安惠霞,杨霞,刘素雁.CAPD患者血脂异常与残余肾功能的相关研究[J].哈尔滨医科大学学报,2009,43(3):275-278. 被引量:6
-
2舒占钧,凌光辉,刘伏友,彭佑铭.腹膜转运机制研究进展[J].中国血液净化,2010,9(3):163-166. 被引量:7
-
3葛燕,孙林,刘伏友.腹膜间皮细胞EMT在腹膜纤维化中的研究进展及意义[J].医学与哲学(B),2010,31(9):46-47. 被引量:6
-
4唐文庄.尿毒症腹膜透析患者血脂变化的临床观察[J].医学临床研究,2010,27(10):1848-1849. 被引量:3
-
5朱志永,凌光辉,刘伏友.腹膜透析超滤衰竭研究进展[J].中国血液净化,2011,10(2):97-99. 被引量:5
-
6蒋红樱,李志鹏,连希艳.腹膜透析患者腹膜超滤衰竭的新靶点:腹膜血管的生成[J].大理学院学报(综合版),2011,10(6):64-67. 被引量:2
-
7孙云松,李永伟,黄克基,李建英,刘先英.中药艾灸神阙穴对腹膜透析患者腹膜超滤功能的影响[J].中国中医药科技,2012,19(5):395-396. 被引量:2
-
8彭鲲,洪大情.维持性腹膜透析患者血脂情况调查及调脂治疗安全性的分析[J].航空航天医学杂志,2012,23(12):1430-1432. 被引量:3
-
9易觅譞,陈国纯,刘伏友.腹膜炎后腹膜透析超滤衰竭的机制研究进展[J].中国血液净化,2012,11(11):588-591. 被引量:9
-
10俞雨生,李建东.腹膜透析超滤衰竭诊断与治疗[J].中国实用内科杂志,2013,33(6):439-441. 被引量:4
二级引证文献6
-
1卫志锋,王琳琳,冯季,杨文,王俊丽,贾倩,郝秀轻,刘圣君.甘草酸二胺对腹膜透析患者腹膜纤维化的影响[J].广东医学,2019,40(1):132-135. 被引量:4
-
2卫志锋,王琳琳,冯季,杨文,王俊丽,贾倩,郝秀轻,刘圣君.甘草酸二胺口服对腹膜透析患者腹膜功能的改善作用及其机制探讨[J].山东医药,2017,57(43):77-79. 被引量:7
-
3卫志锋,王琳琳,冯季,杨文,王俊丽,贾倩,郝秀轻,刘圣君.甘草酸二胺对腹膜透析患者腹膜功能及TGF-β_1、VEGF、CTGF水平的影响[J].山东医药,2018,58(5):55-57. 被引量:6
-
4杨微,丁红.腹膜超滤失败的危险因素分析及干预策略[J].中国继续医学教育,2020,12(21):118-121.
-
5赵晶,崔文鹏,刘美君,杨月,于莉,周文华.腹膜超滤衰竭的危险因素及防治进展[J].中国中西医结合肾病杂志,2020,21(7):647-649. 被引量:2
-
6路静,高洁,孙晶,黄倩,张耀,钟硕,王海萍.载脂蛋白A在高密度脂蛋白中所占比例与维持型腹膜透析患者腹膜溶质转运速率关系的研究[J].临床医学进展,2023,13(1):904-913.
-
1黄丛洋,姚强,钱家麒.腹膜透析超滤衰竭机制的研究进展[J].中国血液净化,2007,6(12):660-662. 被引量:3
-
2孟立锋,杨端云.中医药防治腹膜纤维化的研究进展[J].中国中西医结合肾病杂志,2014,15(9):833-835. 被引量:9
-
3蒋红樱,李志鹏,连希艳.腹膜透析患者腹膜超滤衰竭的新靶点:腹膜血管的生成[J].大理学院学报(综合版),2011,10(6):64-67. 被引量:2
-
4丛亚坤,胡佳林,李影,王桂华,任国庆,隋剑影,姜丽梅.大庆地区腹膜透析患者溶质转运功能变化与其合并症关系的研究[J].中国卫生标准管理,2015,6(24):18-19.
-
5张庆芳,安惠霞,陈晓.脂代谢异常对腹膜透析超滤衰竭的影响[J].中国血液净化,2013,12(7):367-370. 被引量:3
-
6朱起之,童俊容,黄红健.多巴胺在低腹膜转运患者中的运用[J].中国危重病急救医学,1999,11(4):217-219. 被引量:5
-
7方炜,钱家麒,余志远,陈诗书.水孔蛋白1在人腹膜组织的表达及腹膜透析对其表达的影响[J].中华肾脏病杂志,2003,19(1):29-33. 被引量:17
-
8温雯,李月红.2016年国际腹膜透析协会腹膜炎预防和治疗推荐指南解读[J].临床内科杂志,2017,34(1):70-72. 被引量:25
-
9张爱华,范敏华,郑丹侠,杨雪玲.腹膜透析患者CA125水平及腹膜转运功能的纵向观察[J].中国血液净化,2002,1(8):7-9. 被引量:1
-
10李艳,刘章锁,赵占正,高丹,梁献慧.腹膜透析对水通道蛋白3在大鼠腹膜组织表达的影响[J].中华肾脏病杂志,2008,24(9):673-674.